| scholarly article | Q13442814 |
| P2093 | author name string | Jones PL | |
| Rabinovitch M | |||
| Cowan KN | |||
| P2860 | cites work | The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts | Q24620542 |
| Endothelial cell attachment and spreading on human tenascin is mediated by α2β1 and αVβ 3 integrins | Q28298581 | ||
| The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin | Q28369422 | ||
| Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels | Q29619679 | ||
| Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries | Q33890640 | ||
| The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression | Q34197959 | ||
| Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts | Q34223548 | ||
| Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media | Q35750520 | ||
| Apoptosis participates in cellularity regulation during rat aortic intimal thickening | Q35795099 | ||
| Evidence for apoptosis in human atherogenesis and in a rat vascular injury model | Q35796023 | ||
| Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme | Q35796049 | ||
| Death by any other name | Q35796080 | ||
| Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries | Q35831433 | ||
| Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II | Q35831907 | ||
| Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension | Q35832925 | ||
| Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets | Q35833010 | ||
| Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. | Q35833724 | ||
| Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries | Q35833909 | ||
| Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. | Q35834249 | ||
| Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits | Q36209892 | ||
| Hexabrachion proteins in embryonic chicken tissues and human tumors | Q36217535 | ||
| Induction of tenascin in healing wounds | Q36220912 | ||
| Tenascin-C expression by fibroblasts is elevated in stressed collagen gels | Q36235014 | ||
| Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation | Q37355486 | ||
| The role of vascular injury and hemodynamics in rat pulmonary artery remodeling | Q37357731 | ||
| Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle | Q37659597 | ||
| Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions | Q38213354 | ||
| Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts | Q41365080 | ||
| Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments. | Q41377590 | ||
| Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. | Q41492521 | ||
| Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF | Q41588033 | ||
| Regulation of astrocytic tenascin by basic fibroblast growth factor | Q41660078 | ||
| Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. | Q42094189 | ||
| Apoptotic cell death and tissue remodelling during mouse mammary gland involution | Q42462200 | ||
| Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype | Q42756085 | ||
| Expression of tenascin in the developing and adult cerebellar cortex | Q44778655 | ||
| Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis | Q46128262 | ||
| Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina | Q46149107 | ||
| Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. | Q54578066 | ||
| Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration | Q67680428 | ||
| The extracellular matrix of lip wounds in fetal, neonatal and adult mice | Q67710656 | ||
| Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells | Q67900768 | ||
| Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity | Q67905158 | ||
| Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel | Q68025624 | ||
| Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation | Q68202942 | ||
| Proliferation of smooth muscle cells in the inner and outer layers of the tunica media of arteries: an in vitro study | Q70222266 | ||
| Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study | Q70374765 | ||
| Tenascin: a potential role in human arteriovenous PTFE graft failure | Q70994717 | ||
| Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor | Q70998033 | ||
| Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells | Q71090172 | ||
| Functional aspects of vascular tenascin-C expression | Q71695964 | ||
| Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation | Q71834983 | ||
| Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis | Q72034087 | ||
| Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat | Q72133135 | ||
| Apoptosis (programmed cell death) in arteries of the neonatal lamb | Q72455487 | ||
| In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation | Q72523357 | ||
| Heterogeneity in migration of smooth muscle cells from normal and injured rat thoracic aorta in primary culture | Q72641912 | ||
| The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects | Q78321376 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1349-1360 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease | |
| P478 | volume | 150 |
| Q35214557 | Advances in tenascin-C biology |
| Q42759900 | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty |
| Q38105550 | Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension |
| Q33959479 | Apoptosis in the vasculature: mechanisms and functional importance |
| Q46017590 | Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation. |
| Q30429980 | Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease |
| Q37465320 | Cellular and molecular basis of pulmonary arterial hypertension |
| Q40953884 | Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells |
| Q35048823 | ClC-3 chloride channel is upregulated by hypertrophy and inflammation in rat and canine pulmonary artery |
| Q35595010 | Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients |
| Q35916976 | Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension |
| Q91573974 | Drug abuse and HIV-related pulmonary hypertension: double hit injury |
| Q40741643 | Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease |
| Q33805982 | Erythropoietin upregulation in pulmonary arterial hypertension |
| Q37419355 | Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension |
| Q86967025 | Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients |
| Q33784417 | Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension |
| Q39817890 | HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension. |
| Q36541868 | Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling |
| Q26851508 | Immune and inflammatory mechanisms in pulmonary arterial hypertension |
| Q36869381 | In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug |
| Q33898213 | Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension |
| Q38355075 | LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor |
| Q28361811 | Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension |
| Q93204496 | Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1 |
| Q35746579 | Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis |
| Q24634317 | Molecular pathogenesis of pulmonary arterial hypertension |
| Q36736065 | Molecular pathogenesis of pulmonary arterial hypertension |
| Q56388717 | Pathology of pulmonary hypertension |
| Q92772684 | Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension |
| Q34463339 | Predicting rates of cell state change caused by stochastic fluctuations using a data-driven landscape model |
| Q33302400 | Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension |
| Q36502869 | Pulmonary arterial remodeling induced by a Th2 immune response |
| Q24678669 | Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth |
| Q34048479 | Reversal of experimental pulmonary hypertension by PDGF inhibition |
| Q37653353 | Reversible or irreversible remodeling in pulmonary arterial hypertension |
| Q42684671 | Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells |
| Q33636296 | S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4 |
| Q35083293 | S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy |
| Q36045577 | Serotonylated fibronectin is elevated in pulmonary hypertension |
| Q37426657 | Suppression of the expression of hypoxia-inducible factor-1α by RNA interference alleviates hypoxia-induced pulmonary hypertension in adult rats |
| Q36630287 | Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries |
| Q37115911 | Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia |
| Q37814085 | Targeting non-malignant disorders with tyrosine kinase inhibitors. |
| Q35588136 | Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation |
| Q36115781 | Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence |
| Q38308741 | Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q58801368 | The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension |
| Q91653814 | The Search for Disease-Modifying Therapies in Pulmonary Hypertension |
| Q37406387 | Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase II |
| Q37100760 | Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice |
| Q27027862 | Transglutaminase 2-mediated serotonylation in pulmonary hypertension |
| Q37024218 | Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall |
| Q28586021 | Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway |
Search more.